Study of properties of ropivacaine and dexmedetomidine with ropivacaine for upper limb surgeries

Comparison of anesthetic effect of plain ropivacaine versus dexmedetomidine as an adjuvant to ropivacaine in usg guided supra clavicular block for upper limb surgeries

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046660

Enrollment

Registered

2022-10-20

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine 0.75%: For supraclavicular block under usg guidance Control Intervention1: Ropivacaine 0.75% with dexmedetomidine: Supra clavicular Block Under USG Guidance

Eligibility

Inclusion criteria

Inclusion criteria: Patients who giving informed consent

Exclusion criteria

Exclusion criteria: Patients with previous history or clinical presentation with central or peripheral neurological disease 2. Patients with previous history or clinical presentation with central or peripheral coagulopathy. 3. Patients with infection at the site of injection. 4. Patients allergic to any of the study drugs.

Design outcomes

Primary

Measure	Time frame
Duration of analgesia Intra oprative hemodynamic monitoringTimepoint: VAS score at 15 min interval	—

Secondary

Measure	Time frame
Effect of both drugsTimepoint: Every 15 minutes interval after starting of surgery	—

Countries

India

Contacts

Public ContactDr Manish Kumar

Jnuimsrc

Singhalgeetanjali@yahoo.com9829051344

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026